B86

2'-deoxy-5-fluorocytidine

Created:	2009-08-19
Last modified:	2011-06-04

Find Related PDB Entry
1 entries where B86 is found as a standalone ligand2 entries where B86 is found in a polymer sequence

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	29
Chiral Atom Count	3
Bond Count	30
Aromatic Bond Count	0

2D diagram of B86

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	2'-deoxy-5-fluorocytidine
Systematic Name (OpenEye OEToolkits)	4-azanyl-5-fluoro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
Formula	C₉ H₁₂ F N₃ O₄
Molecular Weight	245.208
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	11.02	FC=1C(=NC(=O)N(C=1)C2OC(C(O)C2)CO)N
SMILES	CACTVS	3.352	NC1=NC(=O)N(C=C1F)[CH]2C[CH](O)[CH](CO)O2
SMILES	OpenEye OEToolkits	1.7.0	C1C(C(OC1N2C=C(C(=NC2=O)N)F)CO)O
Canonical SMILES	CACTVS	3.352	NC1=NC(=O)N(C=C1F)[C@H]2C[C@H](O)[C@@H](CO)O2
Canonical SMILES	OpenEye OEToolkits	1.7.0	C1[C@@H]([C@H](O[C@H]1N2C=C(C(=NC2=O)N)F)CO)O
InChI	InChI	1.03	InChI=1S/C9H12FN3O4/c10-4-2-13(9(16)12-8(4)11)7-1-5(15)6(3-14)17-7/h2,5-7,14-15H,1,3H2,(H2,11,12,16)/t5-,6+,7+/m0/s1
InChIKey	InChI	1.03	IDYKCXHJJGMAEV-RRKCRQDMSA-N

Drug Info: DrugBank

DrugBank ID	DB12957
Name	5-fluoro-2'-deoxycytidine
Groups	investigational
Description	5-fluoro-2'-deoxycytidine has been used in trials studying the treatment of Neoplasms, Lung Neoplasms, Breast Neoplasms, Head and Neck Neoplasms, and Urinary Bladder Neoplasms, among others.
Synonyms	5-fluorodeoxycytidine FCdR 5-fluoro-2'-deoxycytidine 5-fluoro-2-deoxycytidine FDCYD
Categories	Deoxyribonucleosides Nucleic Acids, Nucleotides, and Nucleosides Nucleosides Pyrimidine Nucleosides Pyrimidines
CAS number	10356-76-0

Related Resource References

Resource Name	Reference
PubChem	515328
ChEMBL	CHEMBL1076257

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.